Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
Today: 27/07/2026 · FUTURE · Forthcoming · Viewed
Funding agency: Horizon Europe
Call: HORIZON-HLTH-2027-01
Type of action: HORIZON-RIA HORIZON Research and Innovation Actions | Deadline model: single-stage | Planned opening: 10/02/2027 | Model Grant Agreement: HORIZON Action Grant Budget-Based
The Horizon Europe Research and Innovation programme is seeking proposals for the development of monoclonal antibodies to prevent and treat infections from Flaviviruses. The proposed project should aim at developing a therapeutic intervention to combat Flavivirus-induced diseases.
Budget total: 10500000.0 EUR | Budget per project: — EUR
Deadline: 13/04/2027 (260 days left) | Duration: — months | Funding intensity: 100.0% | Type: research
Eligibility: entity types: Research institution, University; countries: EU countries
#Flaviviruses#monoclonal antibodies#infections#therapeutic intervention
Health
Matching by organization
"Rule filter" means the score came from a hard eligibility/preference check, not the AI — if that reasoning looks wrong for a specific organization, use Override below to correct it by hand; the system's own score stays visible for comparison and is never silently replaced.
| Organization | Match % | Source | Rationale | Override |
|---|---|---|---|---|
| Novatex Solutions LTD | 0% | Rule filter |
Excluded by eligibility/preference filters: Org type 'SME' not among eligible en…Excluded by eligibility/preference filters: Org type 'SME' not among eligible entity types ['research institution', 'university']. |
Override |
| European Centre for Emerging Competencies and Technologies | 0% | Rule filter |
Excluded by eligibility/preference filters: Org type 'non-profit' not among elig…Excluded by eligibility/preference filters: Org type 'non-profit' not among eligible entity types ['research institution', 'university']. |
Override |